Luitpold Pharmaceuticals and American Regent

Unknown 2017 Independent Pharmacies

OIG Healthcare Fraud

Penalty

$1.2 million

Outcome

OIG enforcement action against Luitpold Pharmaceuticals and American Regent for healthcare fraud. Penalty: $1.2 million.

Details

Luitpold Pharmaceuticals and American Regent — OIG Enforcement (2017)

OIG took enforcement action against Luitpold Pharmaceuticals and American Regent in 2017 involving healthcare fraud violations in the Independent Pharmacies sector.

Penalty: $1.2 million

Violation types: Healthcare Fraud
Entity type: Pharmacy
Penalty type: Fine

Source: Luitpold Pharmaceuticals and American Regent Agreed to Pay $1.2 Million for Allegedly Violating the Civil Monetary Penalties Law by Paying Remuneration to a Physician and Practice in the Form of Payme

How Crucible Prevents This

Crucible's compliance monitoring controls for Independent Pharmacies would have detected the patterns underlying this violation through automated screening, documentation enforcement, and real-time alert escalation.

Source: Luitpold Pharmaceuticals and American Regent Agreed to Pay $1.2 Million for Allegedly Violating the Civil Monetary Penalties Law by Paying Remuneration to a Physician and Practice in the Form of Payme

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works